Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

1(25.0%)

N/A

1(25.0%)

Phase 4

1(25.0%)

Phase 1

1(25.0%)

4Total

Phase 2(1)

N/A(1)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT07540130Phase 1Active Not Recruiting

Effectiveness of MMS Compared With IFS Among Pregnant Women in Bangladesh: an Experimental Study

Role: lead

NCT05500690Not ApplicableCompleted

Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies

Role: collaborator

NCT04834362Phase 4Completed

Insulin for Hyperglycemia in Stroke Trial

Role: lead

NCT02780570Phase 2Completed

Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients

Role: collaborator

All 4 trials loaded